Metabolic implications of peritoneal dialysis
2012; Volume: 4; Issue: 6 Linguagem: Inglês
10.12968/jorn.2012.4.6.272
ISSN2052-2894
Autores Tópico(s)Electrolyte and hormonal disorders
ResumoJournal of Renal NursingVol. 4, No. 6 ClinicalMetabolic implications of peritoneal dialysisIngi Elsayed, Martin WilkieIngi ElsayedSearch for more papers by this author, Martin WilkieSearch for more papers by this authorIngi Elsayed; Martin WilkiePublished Online:29 Sep 2013https://doi.org/10.12968/jorn.2012.4.6.272AboutSectionsView articleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareShare onFacebookTwitterLinked InEmail View articleReferencesAbbott KC, Oliver DK, Hurst FP, Das NP, Gao SW, Perkins RM (2007) Body mass index and peritoneal dialysis: “exceptions to the exception” in reverse epidemiology? Semin Dial 20(6): 561–5 Crossref, Google ScholarAxelsson J, Heimburger O, Lindholm B, Stenvinkel P (2005) Adipose tissue and its relation to inflammation: the role of adipokines. J Ren Nutr 15(1): 131–6 Crossref, Google ScholarBaxter International Inc (2012) Baxter’s Low Glucose PD solutions Favourably Impacted Metabolic Measures Including Glycemic Control in Trials of Diabetics Undergoing Dialysis. Treatment Regimen May Reduce Cardiovascular Risk Factors in Diabetic Renal Patients www.baxterhealthcare.co.uk/press_room/press_releases/2012/final_impendia_eden_release_11_6_12.pdf (accessed 16 October) Google ScholarCanbakan M, Sahin GM (2007) Icodextrine and insulin resistance in continuous ambulatory peritoneal dialysis patients. Ren Fail 29(3): 289–93 Crossref, Google ScholarFortes PC, de Moraes TP, Mendes JG, Stinghen AE, Ribeiro SC, Pecoits-Filho R (2009) Insulin resistance and glucose homeostasis in peritoneal dialysis. Perit Dial Int 29 Suppl 2: S145–8 Google ScholarHolmes CJ (2007) Glucotoxicity in peritoneal dialysis––solutions for the solution! Adv Chronic Kidney Dis 14(3): 269–78 Crossref, Google ScholarHolmes CJ (2009) Reducing cardiometabolic risk in peritoneal dialysis patients: role of the dialysis solution. J Diabetes Sci Technol 3(6): 1472–80 Crossref, Google ScholarHonda H, Qureshi AR, Axelsson J, Heimburger O, Suliman ME, Barany P, et al. (2007) Obese sarcopenia in patients with end–stage renal disease is associated with inflammation and increased mortality. Am J Clin Nutr 86(3): 633–8 Google ScholarJain AK, Blake P, Cordy P, Garg AX (2012) Global trends in rates of peritoneal dialysis. J Am Soc Nephrol 23(3): 533–44 Crossref, Google ScholarKobayashi S, Maejima S, Ikeda T, Nagase M (2000) Impact of dialysis therapy on insulin resistance in end–stage renal disease: comparison of haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 15(1): 65–70 Crossref, Google ScholarLiem YS, Wong JB, Hunink MG, de Charro FT, Winkelmayer WC (2007) Comparison of hemodialysis and peritoneal dialysis survival in The Netherlands. Kidney Int 71(2): 153–8 Crossref, Google ScholarMarshall J, Jennings P, Scott A, Fluck RJ, McIntyre CW (2003) Glycemic control in diabetic CAPD patients assessed by continuous glucose monitoring system (CGMS). Kidney Int 64(4): 1480–6 Crossref, Google ScholarMcDonald SP, Collins JF, Johnson DW (2003) Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations. J Am Soc Nephrol 14(11): 2894–901 Crossref, Google ScholarMcDonald SP, Marshall MR, Johnson DW, Polkinghorne KR (2009) Relationship between dialysis modality and mortality. J Am Soc Nephrol 20(1): 155–63 Crossref, Google ScholarMcIntyre NJ, Chesterton LJ, John SG et al. (2010) Tissue-advanced glycation end product concentration in dialysis patients. Clin J Am Soc Nephrol 5(1): 51–5 Crossref, Google ScholarMeerwaldt R, Hartog JW, Graaff R et al. (2005) Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients. J Am Soc Nephrol 16(12): 3687–93 Crossref, Google ScholarMircescu G, Garneata L, Florea L et al. (2006) The success story of peritoneal dialysis in Romania: analysis of differences in mortality by dialysis modality and influence of risk factors in a national cohort. Perit Dial Int 26(2): 266–75 Google ScholarPaniagua R, Ventura MD, Avila-Diaz M et al. (2009) Icodextrin improves metabolic and fluid management in high and high-average transport diabetic patients. Perit Dial Int 29(4): 422–32 Google ScholarPark JT, Yoo TH, Kim JK et al. (2012) Leptin/Adiponectin Ratio Is an Independent Predictor of Mortality in Nondiabetic Peritoneal Dialysis Patients. Perit Dial Int Aug 1 Google ScholarSteenkamp R, Castledine C, Feest T, Fogarty D (2010) Chapter 2: UK RRT prevalence in 2009: national and centre-specific analyses. In: UK Renal Registry Thirteenth Annual Report. www.renalreg.com/Report-Area/Report%202010/Chap02_Renal10_web.pdf (accessed 16 October 2012) Google ScholarSuzuki K, Konta T, Ichikawa K et al. (2012) Comparison of Mortality between Japanese Peritoneal Dialysis and Hemodialysis Patients: A 5-Year Multicenter Follow–Up Study. Int J Nephrol 2012(231018): Google ScholarTakatori Y, Akagi S, Sugiyama H et al. (2011) Icodextrin increases technique survival rate in peritoneal dialysis patients with diabetic nephropathy by improving body fluid management: a randomized controlled trial. Clin J Am Soc Nephrol 6(6): 1337–44 Crossref, Google ScholarTjiong HL, Swart R, van den Berg JW, Fieren MW (2009) Amino acid–based peritoneal dialysis solutions for malnutrition: new perspectives. Perit Dial Int 29(4): 384–93 Google ScholarVonesh EF, Snyder JJ, Foley RN, Collins AJ (2006) Mortality studies comparing peritoneal dialysis and hemodialysis: what do they tell us? Kidney Int Suppl 103: S3–11 Crossref, Google ScholarWang X, Axelsson J, Nordfors L et al. (2007) Changes in fat mass after initiation of maintenance dialysis is influenced by the uncoupling protein 2 exon 8 insertion/deletion polymorphism. Nephrol Dial Transplant 22(1): 196–202 Crossref, Google ScholarWilliams ME, Lacson E, Jr., Teng M, Ofsthun N, Lazarus JM (2006) Hemodialyzed type I and type II diabetic patients in the US: Characteristics, glycemic control, and survival. Kidney Int 70(8): 1503–9 Crossref, Google ScholarWolfson M, Ogrinc F, Mujais S (2002) Review of clinical trial experience with icodextrin. Kidney Int Suppl 81: S46–52 Crossref, Google ScholarWu HY, Hung KY, Huang TM et al.. (2012) Safety issues of long–term glucose load in patients on peritoneal dialysis––a 7-year cohort study. PLoS One 7(1): e30337 Crossref, Google ScholarYamauchi T, Kuno T, Takada H, Nagura Y, Kanmatsuse K, Takahashi S (2003) The impact of visceral fat on multiple risk factors and carotid atherosclerosis in chronic haemodialysis patients. Nephrol Dial Transplant 18(9): 1842–7 Crossref, Google Scholar FiguresReferencesRelatedDetails 1 November 2012Volume 4Issue 6ISSN (print): 2041-1448ISSN (online): 2052-2894 Metrics History Published online 29 September 2013 Published in print 1 November 2012 Information© MA Healthcare LimitedKeywordsperitoneal dialysisdialysis fluidsglucosemetabolismdiabetesPDF download
Referência(s)